ADSS1
Adenylosuccinate synthetase isozyme 1
Also known as: ADSSL1, FLJ38602, PURA1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8N142
- Gene
- ADSS1
- Ensembl
- ENSG00000185100
- Chromosome
- 14
- Canonical length
- 457 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes a member of the adenylosuccinate synthase family of proteins. The encoded muscle-specific enzyme plays a role in the purine nucleotide cycle by catalyzing the first step in the conversion of inosine monophosphate (IMP) to adenosine monophosphate (AMP). Mutations in this gene may cause adolescent onset distal myopathy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2016]
Canonical amino-acid sequenceUniProt
457 residues, UniProt reviewed canonical sequence.
>Q8N142|ADSS1
1 MSGTRASNDR PPGAGGVKRG RLQQEAAATG SRVTVVLGAQ WGDEGKGKVV DLLATDADII
61 SRCQGGNNAG HTVVVDGKEY DFHLLPSGII NTKAVSFIGN GVVIHLPGLF EEAEKNEKKG
121 LKDWEKRLII SDRAHLVFDF HQAVDGLQEV QRQAQEGKNI GTTKKGIGPT YSSKAARTGL
181 RICDLLSDFD EFSSRFKNLA HQHQSMFPTL EIDIEGQLKR LKGFAERIRP MVRDGVYFMY
241 EALHGPPKKI LVEGANAALL DIDFGTYPFV TSSNCTVGGV CTGLGIPPQN IGDVYGVVKA
301 YTTRVGIGAF PTEQINEIGG LLQTRGHEWG VTTGRKRRCG WLDLMILRYA HMVNGFTALA
361 LTKLDILDVL GEVKVGVSYK LNGKRIPYFP ANQEMLQKVE VEYETLPGWK ADTTGARRWE
421 DLPPQAQNYI RFVENHVGVA VKWVGVGKSR ESMIQLFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ADSS1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.24
- Highest tissue expression
- 1,193 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 1,193 nTPM
- tongue: 570 nTPM
- heart muscle: 94 nTPM
- blood vessel: 46 nTPM
- liver: 28 nTPM
- choroid plexus: 20 nTPM
Single-cell type
- early spermatids: 478 nCPM
- late primary spermatocytes: 297 nCPM
- thymic myoid cells: 205 nCPM
- late spermatids: 128 nCPM
- myonuclei: 75 nCPM
- müller glia: 60 nCPM
Immune cell
- intermediate monocyte: 0.4 nTPM
- eosinophil: 0.2 nTPM
- naive CD8 T-cell: 0.1 nTPM
- neutrophil: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
Brain region
- choroid plexus: 14 nTPM
- white matter: 13 nTPM
- basal ganglia: 12 nTPM
- hypothalamus: 12 nTPM
- cerebellum: 12 nTPM
- medulla oblongata: 11 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ADSS1.
Disease | AllUniProt
Conditions ADSS1 is implicated in, by any mechanism.
- Myopathy, distal, 5 (MPD5) MIM:617030
Disease | GeneticClinVar
30 pathogenic / likely-pathogenic of 510 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Myopathy, distal, 5
- ADSS1-related disorder
- Arthrogryposis multiplex congenita
- Fetal akinesia deformation sequence 1
- Colon adenocarcinoma
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.84
- gnomAD pLI
- 0
- DepMap mean gene effect
- 0.05
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- 'de novo' AMP biosynthetic process
- AMP biosynthetic process
- AMP salvage
- aspartate metabolic process
- cellular response to electrical stimulus
- cellular response to xenobiotic stimulus
- glutamine metabolic process
- immune system process
- IMP metabolic process
- response to muscle activity
- response to starvation
Molecular functions
- actin filament binding
- adenylosuccinate synthase activity
- GTP binding
- GTPase activity
- identical protein binding
- magnesium ion binding
- phosphate ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Adenylosuccinate synthetase
- Adenylosuccinate synthase, GTP-binding site
- P-loop containing nucleoside triphosphate hydrolase
- Adenylosuccinate synthase, active site
- Adenylosuccinate synthetase, domain 1
- Adenylosuccinate synthetase, domain 2
- Adenylosuccinate synthetase, domain 3
- Adenylosuccinate synthetase
- Adenylosuccinate synthetase isozyme 1, chordates
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ADSS1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ADSS1 as an antibody target. Whether an autoantibody or antibody against ADSS1 could matter depends on whether native ADSS1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ADSS1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ADSS1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...